Applied BioCode Corporation 6598.TW Stock
Applied BioCode Corporation Price Chart
Applied BioCode Corporation 6598.TW Financial and Trading Overview
Applied BioCode Corporation stock price | 20.6 TWD |
Previous Close | 26.8 TWD |
Open | 27.6 TWD |
Bid | 27.1 TWD x N/A |
Ask | 27.15 TWD x N/A |
Day's Range | 26.9 - 27.6 TWD |
52 Week Range | 23.2 - 34.9 TWD |
Volume | 112.19K TWD |
Avg. Volume | 98.59K TWD |
Market Cap | 2.22B TWD |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | -2.01 TWD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
6598.TW Valuation Measures
Enterprise Value | 1.46B TWD |
Trailing P/E | N/A |
Forward P/E | -16.96875 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 5.2988257 |
Price/Book (mrq) | 2.9209251 |
Enterprise Value/Revenue | 3.493 |
Enterprise Value/EBITDA | -11.229 |
Trading Information
Applied BioCode Corporation Stock Price History
Beta (5Y Monthly) | N/A |
52-Week Change | -20.71% |
S&P500 52-Week Change | 20.43% |
52 Week High | 34.9 TWD |
52 Week Low | 23.2 TWD |
50-Day Moving Average | 27.72 TWD |
200-Day Moving Average | 28.28 TWD |
6598.TW Share Statistics
Avg. Volume (3 month) | 98.59K TWD |
Avg. Daily Volume (10-Days) | 71.56K TWD |
Shares Outstanding | 81.77M |
Float | N/A |
Short Ratio | N/A |
% Held by Insiders | 42.50% |
% Held by Institutions | 0.045% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | -38.57% |
Operating Margin (ttm) | -41.27% |
Gross Margin | 63.07% |
EBITDA Margin | -31.10% |
Management Effectiveness
Return on Assets (ttm) | -10.15% |
Return on Equity (ttm) | -19.96% |
Income Statement
Revenue (ttm) | 418.96M TWD |
Revenue Per Share (ttm) | 5.13 TWD |
Quarterly Revenue Growth (yoy) | 53.00% |
Gross Profit (ttm) | N/A |
EBITDA | -130315000 TWD |
Net Income Avi to Common (ttm) | -161636000 TWD |
Diluted EPS (ttm) | -1.96 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 774.54M TWD |
Total Cash Per Share (mrq) | 9.47 TWD |
Total Debt (mrq) | 44.99M TWD |
Total Debt/Equity (mrq) | 5.92 TWD |
Current Ratio (mrq) | 10.766 |
Book Value Per Share (mrq) | 9.295 |
Cash Flow Statement
Operating Cash Flow (ttm) | 121.19M TWD |
Levered Free Cash Flow (ttm) | -92928376 TWD |
Profile of Applied BioCode Corporation
Country | Taiwan |
State | CA |
City | Santa Fe Springs |
Address | 12130 Mora Dr. |
ZIP | 90670 |
Phone | 833 246 2633 |
Website | https://www.apbiocode.com |
Industry | Medical Devices |
Sector(s) | Healthcare |
Full Time Employees | N/A |
Applied BioCode Corporation designs, develops, manufactures, and commercializes multiplex diagnostic testing products for the In-Vitro diagnostics market. The company's products include the BioCode MDx 3000 system, an automated molecular diagnostic system that automates the PCR amplification, hybridization, and detection steps of molecular testing; and the BioCode 2500 analyzer, a system that reads barcoded magnetic beads (BMB) and displays the barcode and fluorescence intensity for each BMB. In addition, It develops assays, such as BioCode SARS-CoV-2 Assay, a high volume automated nucleic acid multiplex assay for the detection of SARS-CoV-2 nucleic acid in nasopharyngeal swabs; BioCode Respiratory Pathogen Panels, which simultaneously detects and differentiates the presence of 17 respiratory pathogens in nasopharyngeal swabs; BioCode gastrointestinal (GI) pathogen panels for common GI pathogens, including viruses, bacteria, and parasites that cause infectious diarrhea; and MDx assays pipeline for various molecular tests. Further, the company offers fungal pathogen analyte specific reagents; human cytokine/chemokine multiplex kits to identify relevant biomarkers; mouse premixed multiplex kits and custom panels for enhancing flexibility in experimental design allowing the user to pick and choose their own analytes panel; and rat, monkey, canine, and non-human primate cytokine/chemokine multiplex kits. Additionally, the company provides BMB, calibration beads, and coupling kits for various bioassay applications; ELISA, a tool for the quantitative measurement of drug/protein/antibody levels in biological samples comprising cell lysate or serum; and various assay development services. Applied BioCode Corporation is based in Santa Fe Springs, California.
Q&A For Applied BioCode Corporation Stock
What is a current 6598.TW stock price?
Applied BioCode Corporation 6598.TW stock price today per share is 20.6 TWD.
How to purchase Applied BioCode Corporation stock?
You can buy 6598.TW shares on the Taiwan exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Applied BioCode Corporation?
The stock symbol or ticker of Applied BioCode Corporation is 6598.TW.
Which industry does the Applied BioCode Corporation company belong to?
The Applied BioCode Corporation industry is Medical Devices.
How many shares does Applied BioCode Corporation have in circulation?
The max supply of Applied BioCode Corporation shares is 81.77M.
What is Applied BioCode Corporation Price to Earnings Ratio (PE Ratio)?
Applied BioCode Corporation PE Ratio is now.
What was Applied BioCode Corporation earnings per share over the trailing 12 months (TTM)?
Applied BioCode Corporation EPS is -2.01 TWD over the trailing 12 months.
Which sector does the Applied BioCode Corporation company belong to?
The Applied BioCode Corporation sector is Healthcare.